EU Finds Anti-Competitive Abuse Of Pharmaceutical Patents, Launches Antitrust Action
Pharmaceutical companies are manipulating the intellectual property rights system and are “actively trying to delay the entry of generic medicines onto their markets,” a top EU official said of an EU inquiry into the pharmaceutical sector released Wednesday. As a result, there has been a decline in the number of innovative medicines getting to the market, it says.

Indigenous people and governments like the United States' may be able to help each other, especially when it comes to protecting traditional knowledge while also using it combat global crises like climate change, says Terry Williams of the Tulalip Tribes. But additional protection for traditional knowledge is needed.